rolipram has been researched along with Cardiovascular Stroke in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to determine whether the selective type IV cAMP-phosphodiesterase inhibitor rolipram could reduce the reperfusion injury that occurs during myocardial infarction in the anesthetized dog." | 3.68 | Inhibition of granulocyte cAMP-phosphodiesterase by rolipram in vivo is not sufficient to protect the canine myocardium from reperfusion injury. ( Clay, MP; Lindstrom, TD; Schelm, JA; Simpson, PJ; Smallwood, JK, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hussain, RI | 1 |
| Aronsen, JM | 1 |
| Afzal, F | 1 |
| Sjaastad, I | 1 |
| Osnes, JB | 1 |
| Skomedal, T | 1 |
| Levy, FO | 1 |
| Krobert, KA | 1 |
| Glover, DK | 1 |
| Riou, LM | 1 |
| Ruiz, M | 1 |
| Sullivan, GW | 1 |
| Linden, J | 1 |
| Rieger, JM | 1 |
| Macdonald, TL | 1 |
| Watson, DD | 1 |
| Beller, GA | 1 |
| McVey, M | 1 |
| Perrone, MH | 1 |
| Clark, KL | 1 |
| Simpson, PJ | 1 |
| Schelm, JA | 1 |
| Smallwood, JK | 1 |
| Clay, MP | 1 |
| Lindstrom, TD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Aminophylline on Preventing Acute Kidney Injury in Pediatric Patients Undergoing Open Heart Surgery[NCT03897335] | Phase 3 | 80 participants (Anticipated) | Interventional | 2019-02-07 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for rolipram and Cardiovascular Stroke
| Article | Year |
|---|---|
The functional activity of inhibitory G protein (G(i)) is not increased in failing heart ventricle.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Carbachol; Cardiotonic Agents; GTP-Binding Pro | 2013 |
Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine A2 Receptor Agonists; Animals; Cardiotonic Agents; Co | 2005 |
Does tumor necrosis factor-alpha (TNF-alpha) contribute to myocardial reperfusion injury in anesthetized rats?
Topics: Anesthesia; Animals; Blood Pressure; Enzyme-Linked Immunosorbent Assay; Heart Rate; Male; Myocardial | 1999 |
Inhibition of granulocyte cAMP-phosphodiesterase by rolipram in vivo is not sufficient to protect the canine myocardium from reperfusion injury.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Blood Pressure; Coronary Circulation; Dogs; Granulocyt | 1992 |